Patents by Inventor Stephen Macmahon

Stephen Macmahon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260124187
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker, wherein the dose of each component is below the lowest dose approved for the treatment of hypertension for the component.
    Type: Application
    Filed: November 7, 2025
    Publication date: May 7, 2026
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Publication number: 20260060968
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: November 11, 2025
    Publication date: March 5, 2026
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Publication number: 20260027093
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: September 26, 2025
    Publication date: January 29, 2026
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Patent number: 12521380
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Grant
    Filed: March 7, 2025
    Date of Patent: January 13, 2026
    Assignee: THE GEORGE INSTITUTE FOR GLOBAL HEALTH
    Inventors: Anthony Rodgers, Stephen Macmahon
  • Patent number: 12465599
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Grant
    Filed: April 1, 2025
    Date of Patent: November 11, 2025
    Assignee: THE GEORGE INSTITUTE FOR GLOBAL HEALTH
    Inventors: Anthony Rodgers, Stephen Macmahon
  • Publication number: 20250312325
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: April 1, 2025
    Publication date: October 9, 2025
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Publication number: 20250205210
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: March 7, 2025
    Publication date: June 26, 2025
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Patent number: 12285415
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Grant
    Filed: August 8, 2023
    Date of Patent: April 29, 2025
    Assignee: THE GEORGE INSTITUTE FOR GLOBAL HEALTH
    Inventors: Anthony Rodgers, Stephen Macmahon
  • Patent number: 12102623
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Grant
    Filed: September 16, 2022
    Date of Patent: October 1, 2024
    Assignee: THE GEORGE INSTITUTE FOR GLOBAL HEALTH
    Inventors: Anthony Rodgers, Stephen MacMahon
  • Publication number: 20230381161
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: August 8, 2023
    Publication date: November 30, 2023
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Publication number: 20230125076
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: December 16, 2022
    Publication date: April 27, 2023
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Publication number: 20230087834
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: September 16, 2022
    Publication date: March 23, 2023
    Inventors: Anthony RODGERS, Stephen MacMAHON
  • Patent number: 11478462
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Grant
    Filed: September 8, 2020
    Date of Patent: October 25, 2022
    Assignee: THE GEORGE INSTITUTE FOR GLOBAL HEALTH
    Inventors: Anthony Rodgers, Stephen MacMahon
  • Publication number: 20220226316
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of diabetes and associated conditions, diseases, and disorders.
    Type: Application
    Filed: November 15, 2021
    Publication date: July 21, 2022
    Inventors: Stephen MacMAHON, Anthony RODGERS
  • Publication number: 20220226315
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of diabetes and associated conditions, diseases, and disorders.
    Type: Application
    Filed: November 15, 2021
    Publication date: July 21, 2022
    Inventors: Stephen MacMAHON, Anthony RODGERS
  • Publication number: 20220226317
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of diabetes and associated conditions, diseases, and disorders.
    Type: Application
    Filed: November 15, 2021
    Publication date: July 21, 2022
    Inventors: Stephen MacMAHON, Anthony RODGERS
  • Publication number: 20220184070
    Abstract: Pharmaceutical compositions useful in the treatment of metabolic disorders including diabetes, the compositions comprising a) a dipeptidyl peptidase IV (DPP IV) inhibitor such as sitagliptin, b) a biguanide such as metformin, and c) a sulfonylurea such as glimepiride, wherein each one of the DPPIV inhibitor, biguanide and sulfonylurea are at a dose that is at about 20-75% of the lowest diabetes therapeutic dose (LDTD).
    Type: Application
    Filed: March 25, 2020
    Publication date: June 16, 2022
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Publication number: 20210260056
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of diabetes and associated conditions, diseases, and disorders.
    Type: Application
    Filed: May 11, 2021
    Publication date: August 26, 2021
    Inventors: Stephen MacMAHON, Anthony RODGERS
  • Patent number: 11033544
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of diabetes and associated conditions, diseases, and disorders.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: June 15, 2021
    Assignee: THE GEORGE INSTITUTE FOR GLOBAL HEALTH
    Inventors: Stephen MacMahon, Anthony Rodgers
  • Publication number: 20200397770
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: September 8, 2020
    Publication date: December 24, 2020
    Inventors: Anthony RODGERS, Stephen MacMAHON